Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and antiviral agents. Its structure supports the formation of guanidine-containing molecules, which are known for strong hydrogen bonding and improved bioavailability. Commonly employed in medicinal chemistry for optimizing drug candidates targeting metabolic and infectious diseases. Also utilized in research settings for modifying peptide-like structures to enhance stability and receptor binding affinity.